Ilumya Treatment

Watch the Video

What Is Ilumya?

Ilumya (tildrakizumab-asmn) is a prescription biologic medication used to treat moderate-to-severe plaque psoriasis in adults who are candidates for systemic therapy. Plaque psoriasis develops when the immune system becomes overactive, triggering inflammation that leads to skin cell buildup. Ilumya works by targeting specific inflammatory pathways involved in this process, helping reduce the immune response that causes psoriasis symptoms.

This medication is administered as a subcutaneous injection by a healthcare professional. Unlike daily oral medications, Ilumya requires only periodic dosing, making it a practical option for many patients seeking effective long-term management of their condition.

Person covering their face with both hands, showing plaque psoriasis patches on the forearms and elbows against a white background.

Condition Overview: Plaque Psoriasis

Plaque psoriasis is a chronic autoimmune condition affecting millions of adults. It causes raised, red patches covered with silvery-white scales, most commonly appearing on the elbows, knees, scalp, and lower back. Symptoms often include persistent itching, burning sensations, and skin discomfort.

Beyond physical symptoms, plaque psoriasis can significantly impact emotional well-being and daily activities. Many patients experience self-consciousness about visible plaques, affecting their confidence in social and professional settings. If you notice persistent skin changes, consulting a dermatologist is essential for proper diagnosis and exploring treatment options tailored to your needs.

How Ilumya Treatment Works

Ilumya is administered as a subcutaneous injection in an outpatient clinical setting. Treatment begins with two initial doses given four weeks apart, followed by maintenance injections every twelve weeks thereafter, as prescribed by your physician.

Each appointment is designed for your comfort and safety. Upon arrival, our clinical team will review your health status and prepare your injection. The administration itself takes only moments, though we ask patients to remain briefly for post-injection monitoring.

During your visit, our staff observes for any immediate reactions and answers questions about your treatment plan. Our outpatient centers feature comfortable seating, climate-controlled environments, and attentive care throughout your appointment. We prioritize creating a calm, supportive atmosphere so you can focus on your health.

  • Experienced clinical teams trained specifically in injectable and infusion medications
  • Comfortable outpatient centers designed for patient convenience and relaxation
  • Insurance verification support to help clarify coverage before treatment begins
  • Flexible scheduling with appointment times that accommodate your routine
  • Provider communication, ensuring your referring physician stays informed of your progress

Organizational Resources

The Gout Education Society is a nonprofit organization that provides free resources for people with gout and medical professionals. Their goal is to improve the quality of care for gout and ensure more patients receive a proper diagnosis and treatment.

Learn more

The Gout Support Group of America is dedicated to raising awareness of gout, one of the most common forms of arthritis, to improve the overall quality of care through education, empowerment, and community. 

Learn more

The Alliance for Gout Awareness (AfPA) is an organization that aims to raise awareness about gout and address common misconceptions. They offer resources to help patients, families, and doctors manage gout.

Learn more

New Patient Resources

Referral Process

Referring a patient for Ilumya treatment at TwelveStone is straightforward. Physicians can submit referrals through our online portal, fax, or phone. Once received, our intake team contacts the patient promptly to schedule their first appointment.

We handle insurance verification and prior authorization on your behalf, reducing administrative burden for both providers and patients. Throughout treatment, we maintain communication with referring physicians, providing updates and coordinating care as needed. Our goal is to remove barriers so patients can begin therapy without unnecessary delays.

What Patients Can Expect During Visits

Your comfort matters throughout every visit. When you arrive, our front desk staff will check you in and guide you to the treatment area. A clinical team member will confirm your medical information and prepare your injection.

The injection is administered quickly by trained nursing staff. Afterward, you’ll remain in our care center briefly while we monitor for any reactions. Our treatment areas offer comfortable seating and a welcoming environment. Staff members are available to answer questions and provide support, ensuring you feel informed and cared for during each appointment.

Clinician in blue scrubs with a stethoscope reviews information on a tablet with an older patient, both smiling during a consultation.

FAQs About Ilumya Treatment

After two initial doses four weeks apart, Ilumya is administered every twelve weeks.

Most visits last approximately 30 to 60 minutes, including check-in and monitoring.

Many insurance plans cover Ilumya. Our team verifies your coverage and assists with prior authorization.

Yes. Clinical staff monitors you during and after each injection and addresses any concerns.

Some patients see results within a few weeks, though responses vary. Your physician will assess your progress over time.

View through glass into TwelveStone Health Partners reception and waiting area, with the logo and office hours printed on the door.

Start Your Ilumya Treatment Today

Ready to begin Ilumya treatment or refer a patient? Contact TwelveStone Health Partners to submit a referral, schedule a consultation, or locate a treatment center near you. Our team is here to support you through every step of your care journey.